
Urapidil hydrochloride
CAS No. 64887-14-5
Urapidil hydrochloride( —— )
Catalog No. M15462 CAS No. 64887-14-5
Urapidil hydrochloride is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 37 | In Stock |
![]() ![]() |
100MG | 59 | In Stock |
![]() ![]() |
200MG | 85 | In Stock |
![]() ![]() |
500MG | 142 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameUrapidil hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrapidil hydrochloride is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist.
-
DescriptionUrapidil hydrochloride is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist.(In Vivo):Urapidil (p.o. or i.v.) causes sedation and decreased tonus in mice and rats.
-
In Vitro——
-
In VivoUrapidil (p.o. or i.v.) causes sedation and decreased tonus in mice and rats.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT| α-adrenergic receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number64887-14-5
-
Formula Weight423.94
-
Molecular FormulaC20H29N5O3·HCl
-
Purity>98% (HPLC)
-
SolubilityEthanol: 1 mg/mL (2.35 mM); Water: 85 mg/mL (200.5 mM); DMSO: 24 mg/mL (56.61 mM)
-
SMILESCl.COC1=CC=CC=C1N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Luchini L, et al. Minerva Anestesiol. 1991 Sep;57(9):702-3.
molnova catalog



related products
-
Brompheniramine hydr...
Brompheniramine maleate is a histamine H1 receptors antagonist.
-
Dapoxetine HCl
Dapoxetine HCl is a selectivity short-acting serotonin reuptake inhibitor used for the therapy of premature ejaculation.
-
CART (62-76) (rat, h...
Cocaine- and amphetamine-regulated transcript (CART) peptide fragment that inhibits food intake. Attenuates NPY-induced feeding and decreases food intake in food-restricted goldfish, and induces anxiogenic-like effects in elevated plus-maze test in rats. Modulates the activity of striatal noradrenergic, and corticostrial and hypothalamic serotoninergic systems, with no major effect on dopaminergic pathways in rat brain.